[1] |
JENNINGS L,HUANG Q S,BARR I,et al.Literature review of the epidemiology of influenza B disease in 15 countries in the Asia-Pacific region[J]. Influenza Other Respir Viruses,2018,12(3):383-411.
|
[2] |
闫若潜,杜向党. 流感病毒基因组结构及其编码蛋白研究进展[J]. 动物医学进展,2004,25(1):32-35.
|
[3] |
房师松,王昕. 甲型流感病毒宿主特异性与适应性进化[J]. 国际病毒学杂志,2019,26(6):426-430.
|
[4] |
ZHANG R,CHEN T,OU X,et al.Clinical,epidemiological and virological characteristics of the first detected human case of avian influenza A(H5N6) virus[J]. Infect Genet Evol,2016,40:236-242.
|
[5] |
TRAN D,VAUDRY W,MOORE D,et al.Hospitalization for influenza A versus B[J]. Pediatrics,2016,138(3):e20154643.
|
[6] |
ZHAI S L,ZHANG H,CHEN S N,et al.Influenza D virus in animal species in Guangdong province,southern China[J]. Emerg Infect Dis,2017,23(8):1392-1396.
|
[7] |
钟慧君,李慧锦,杨勇. 87例流感合并肺炎支原体感染患儿临床特征[J]. 中国感染控制杂志,2019,18(12):1154-1158.
|
[8] |
LI S,LIU S S,ZHU A Q,et al.The mortality burden of influenza in China:a systematic review[J]. Zhonghua Yu Fang Yi Xue Za Zhi,2019,53(10):1049-1055.
|
[9] |
LIU S,SHA J,YU Z,et al.Avian influenza virus in pregnancy[J]. Rev Med Virol,2016,26(4):268-284.
|
[10] |
BELSER J A,LASH R R,GARG S,et al.The eyes have it:influenza virus infection beyond the respiratory tract[J]. Lancet Infect Dis,2018,18(7):e220-e227.
|
[11] |
PETERANDERL C,HEROLD S,SCHMOLDT C.Human influenza virus infections[J]. Semin Respir Crit Care Med,2016,37(4):487-500.
|
[12] |
DHARMAPALAN D.Influenza[J]. Indian J Pediatr,2020,87:828-832.
|
[13] |
WANG X,SUN Q,YE Z,et al.Computational approach for predicting the conserved B-cell epitopes of hemagglutinin H7 subtype influenza virus[J]. Exp Ther Med,2016,12(4):2439-2446.
|
[14] |
KIM K S,JUNG H,SHIN I K,et al.Induction of interleukin-1 beta(IL-1β) is a critical component of lung inflammation during influenza A(H1N1) virus infection[J]. J Med Virol,2015,87(7):1104-1112.
|
[15] |
CARLIN A F,PLUMMER E M,VIZCARRA E A,et al.An IRF-3-,IRF-5-,and IRF-7-independent pathway of dengue viral resistance utilizes IRF-1 to stimulate type Ⅰ and Ⅱ interferon responses[J]. Cell Rep,2017,21(6):1600-1612.
|
[16] |
HARADA K.Sclerosing and obstructive cholangiopathy in biliary atresia:mechanisms and association with biliary innate immunity[J]. Pediatr Surg Int,2017,33(12):1243-1248.
|
[17] |
KURIAKOSE T,KANNEGANTI T D.Regulation and functions of NLRP3 inflammasome during influenza virus infection[J]. Mol Immunol,2017,86:56-64.
|
[18] |
WANG B,LAM T H,SOH M K,et al.Influenza A virus facilitates its infectivity by activating p53 to inhibit the expression of interferon-induced transmembrane proteins[J]. Front Immunol,2018,9:1193.
|
[19] |
SEONG M W,CHO S I,PARK H,et al.Genotyping influenza virus by next-generation deep sequencing in clinical specimens[J]. Ann Lab Med,2016,36(3):255-258.
|
[20] |
VEMULA S V,ZHAO J,LIU J,et al.Current approaches for diagnosis of influenza virus infections in humans[J]. Viruses,2016,8(4):96.
|
[21] |
KRITTANAI S,KITISRIPANYA T,UDOMSIN O,et al.Development of a colloidal gold nanoparticle-based immunochromatographic strip for the one-step detection of miroestrol and puerarin[J]. Biomed Chromatogr,2018,32(11):e4330.
|
[22] |
ZHAO J,LIU J,VEMULA S V,et al.Sensitive detection and simultaneous discrimination of influenza A and B viruses in nasopharyngeal swabs in a single assay using next-generation sequencing-based diagnostics[J]. PLoS One,2016,11(9):e0163175.
|
[23] |
LEE H K,LEE C K,TANG J W T,et al. Contamination-controlled high-throughput whole genome sequencing for influenza A viruses using the MiSeq sequencer[J]. Sci Rep,2016,6:33318.
|
[24] |
SHEN K M,SABBAVARAPU N M,FU C Y,et al.An integrated microfluidic system for rapid detection and multiple subtyping of influenza A viruses by using glycan-coated magnetic beads and RT-PCR[J]. Lab Chip,2019,19(7):1277-1286.
|
[25] |
LU P H,MA Y D,FU C Y,et al.A structure-free digital microfluidic platform for detection of influenza a virus by using magnetic beads and electromagnetic forces[J]. Lab Chip,2020,20(4):789-797.
|
[26] |
KATZEN J,KOHN R,HOUK J L,et al.Early oseltamivir after hospital admission is associated with shortened hospitalization:a 5-year analysis of oseltamivir timing and clinical outcomes[J]. Clin Infect Dis,2019,69(1):52-58.
|
[27] |
JIA X,LIU B,BAO L,et al.Delayed oseltamivir plus sirolimus treatment attenuates H1N1 virus-induced severe lung injury correlated with repressed NLRP3 inflammasome activation and inflammatory cell infiltration[J]. PLoS Pathog,2018,14(11):e1007428.
|
[28] |
CHEN J Y,WEI S K,LAI C C,et al.A Meta-analysis comparing the efficacy and safety of peramivir with other neuraminidase inhibitors for influenza treatment[J]. Medicina(Kaunas),2020,56(2):63.
|
[29] |
SCOTT L J.Correction to:peramivir:a review in uncomplicated influenza[J]. Drugs,2018,78( 14 ):1525.
|
[30] |
WANG P C,CHIU D C,JAN J T,et al.Peramivir conjugates as orally available agents against influenza H 275Y mutant[J]. Eur J Med Chem,2018,145:224-234 .
|
[31] |
OH D Y,PANOZZO J,VITESNIK S,et al.Selection of multi-drug resistant influenza A and B viruses under zanamivir pressure and their replication fitness in ferrets[J]. Antivir T her,2018,23( 4):295-306 .
|
[32] |
NOSHI T,KITANO M,TANIGUCHI K,et al.In vitro characterization of baloxavir acid,a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunit[J]. Antiviral Res,2018,160:109-117.
|
[33] |
HAYDEN F G,SUGAYA N,HIROTSU N,et al.Baloxavir marboxil for uncomplicated influenza in adults and adolescents[J]. N Engl J Med,2018,379(10):913-923.
|
[34] |
世界卫生组织,季节性流感[EB/OL](2018-03-31)[2020-02-20]. .
|
[35] |
罗剑,李秀玲. 基于细胞培养的流感疫苗研究进展[J]. 中国新药杂志,2019,28(21):2594-2599.
|
[36] |
李文娟,王大燕. 我国流感疾病负担相关研究进展[J]. 中国人兽共患病学报,2019,35(10):928-933.
|
[37] |
SHAHAM A,CHODICK G,SHALEV V,et al.Personal and social patterns predict influenza vaccination decision[J]. BMC Public Health,2020,20(1):222.
|